Durogesic DTrans opioid tolerance

The prescribing information for Durogesic DTrans (fentanyl patch) has been updated to include details regarding initial dose selection and use in opioid-naïve patients.

Durogesic DTrans should only be used in patients who have demonstrated opioid tolerance.

The initial dose should be based on the patient’s opioid history, including the degree of opioid tolerance, if any, as well as on the current general condition and medical status of the patient.

In strong opioid-naïve patients, treatment should be initiated with the 25 microgram per hour patch.

Clinical experience is limited in opioid-naïve patients. If therapy is considered appropriate in these patients, titrate with low doses of short-acting opioids before converting to Durogesic DTrans 25 microgram per hour.

View Durogesic DTrans drug record

Further information: Janssen-Cilag Ltd

Want news like this straight to your inbox?
Sign up for our bulletins

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register
Already registered?
Sign in

MIMS Product Slides

Product overviews prepared by the MIMS team, in a handy slide format.

Click here

Slides are initiated, funded & reviewed by the companies specified.

MIMS Dermatology

Read the latest issue online exclusively on MIMS Learning.

Read MIMS Dermatology

MIMS app

Access the full drug database and quick-reference tables on the go

Find out more